Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0C6VV
|
||||
Former ID |
DCL001125
|
||||
Drug Name |
Prolarix
|
||||
Synonyms |
Prolarix (TN)
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Cancer [ICD9: 140-229; ICD10:C00-C96] | Phase 2 | [522427] | ||
Therapeutic Class |
Anticancer Agents
|
||||
Company |
Protherics
|
||||
Structure |
Download2D MOL |
||||
Formula |
C8H11N3O2
|
||||
Canonical SMILES |
C1C=CN(C=C1C(=O)N)CC(=O)N
|
||||
InChI |
1S/C8H11N3O2/c9-7(12)5-11-3-1-2-6(4-11)8(10)13/h1,3-4H,2,5H2,(H2,9,12)(H2,10,13)
|
||||
InChIKey |
WEJRSYKFMCUCRQ-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | NRH dehydrogenase [quinone] 2 | Target Info | Inhibitor | [550543] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.